Response to Neoadjuvant Chemo for Breast Cancer Varies by Sex
Men have lower rates of pathologic complete response than women across tumor subtypes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Men have lower rates of pathologic complete response than women across tumor subtypes
Only registered members have full access to PracticeUpdate content.